Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents

Neuroscience

Volumn 151, Issue 1, 2008, Pages 92-103

  Chou, J ^a   Luo, Y ^a   Kuo, C C ^a   Powers, K ^a   Shen, H ^a   Harvey, B K ^a   Hoffer, B J ^a   Wang, Y ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

bone morphogenetic protein 7; degeneration; gene expression; methamphetamine; protection; tyrosine hydroxylase

Indexed keywords

BETA GALACTOSIDASE; MESSENGER RNA; METHAMPHETAMINE; OSTEOGENIC PROTEIN 1; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG ABUSE; EMBRYO; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOREACTIVITY; LOCOMOTION; MESENCEPHALON; MOLECULAR INTERACTION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NICK END LABELING; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RODENT;

ANIMALS; BETA-GALACTOSIDASE; BONE MORPHOGENETIC PROTEINS; CELL COUNT; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MESENCEPHALON; METHAMPHETAMINE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TYROSINE 3-MONOOXYGENASE;

EID: 37849022387     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.10.044     Document Type: Article

References (17)

1. Cadet J.L., Jayanthi S., and Deng X. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J 17 (2003) 1775-1788
2. Chang C.F., Morales M., Chou J., Chen H.L., Hoffer B.J., and Wang Y. Bone morphogenetic proteins are involved in fetal kidney tissue transplantation-induced neuroprotection in stroke rats. Neuropharmacology 43 (2002) 418-426
3. Chen H.L., Lein P.J., Wang J.Y., Gash D., Hoffer B.J., and Chiang Y.H. Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals. Brain Res 994 (2003) 81-90
4. Cox S., Harvey B.K., Sanchez J.F., Wang J.Y., and Wang Y. Mediation of BMP7 neuroprotection by MAPK and PKC in rat primary cortical cultures. Brain Res 1010 (2004) 55-61
5. Deng X., Cai N.S., McCoy M.T., Chen W., Trush M.A., and Cadet J.L. Methamphetamine induces apoptosis in an immortalized rat striatal cell line by activating the mitochondrial cell death pathway. Neuropharmacology 42 (2002) 837-845
6. Deng X., Wang Y., Chou J., and Cadet J.L. Methamphetamine causes widespread apoptosis in the mouse brain: Evidence from using an improved TUNEL histochemical method. Mol Brain Res 93 (2001) 64-69
7. Godin R.E., Takaesu N.T., Robertson E.J., and Dudley A.T. Regulation of BMP7 expression during kidney development. Development 125 (1998) 3473-3482
8. Harvey B.K., Mark A., Chou J., Chen G.J., Hoffer B.J., and Wang Y. Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease. Brain Res 1022 (2004) 88-95
9. Jordan J., Bottner M., Schluesener H.J., Unsicker K., and Krieglstein K. Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells. Eur J Neurosci 9 (1997) 1699-1709
10. Koike K., Hashimoto K., Fukami G., Okamura N., Zhang L., Ohgake S., Koizumi H., Matsuzawa D., Kawamura N., Shimizu E., and Iyo M. The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum. Neuropharmacology 48 (2005) 391-397
11. LaVoie M.J., and Hastings T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J Neurosci 19 (1999) 1484-1491
12. Lee J.Y., Koh H.C., Chang M.Y., Park C.H., Lee Y.S., and Lee S.H. Erythropoietin and bone morphogenetic protein 7 mediate ascorbate-induced dopaminergic differentiation from embryonic mesencephalic precursors. Neuroreport 14 (2003) 1401-1404
13. Lin S.Z., Hoffer B.J., Kaplan P., and Wang Y. Osteogenic protein-1 protects against cerebral infarction induced by MCA-ligation in adult rats. Stroke 30 (1999) 126-133
14. Mark K.A., Soghomonian J.J., and Yamamoto B.K. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J Neurosci 24 (2004) 11449-11456
15. NSDUH Report (2005) Methamphetamine use, abuse, and dependence: 2002, 2003, and 2004. Substance Abuse and Mental Health Service Administration.
16. Soderstrom S., Bengtsson H., and Ebendal T. Expression of serine/threonine kinase receptors including the bone morphogenetic factor type II receptor in the developing and adult rat brain. Cell Tissue Res 286 (1996) 269-279
17. Zuch C.L., Nordstroem V.K., Briedrick L.A., Hoernig G.R., Granholm A.C., and Bickford P.C. Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion. J Comp Neurol 427 (2000) 440-454